Neuropsychopharmacology
- Potential therapeutics for effort-related motivational dysfunction: assessing novel atypical dopamine transport inhibitors2 years ago
- GABA release from central amygdala neurotensin neurons differentially modulates ethanol consumption in male and female mice2 years ago
- Bridging minds and policies: supporting early career researchers in translating computational psychiatry research2 years ago
- Stimulant medications in children with ADHD normalize the structure of brain regions associated with attention and reward2 years ago
- Ghrelin decreases sensitivity to negative feedback and increases prediction-error related caudate activity in humans, a randomized controlled trial2 years ago
- Dissecting the genetic overlap between severe mental disorders and markers of cellular aging: Identification of pleiotropic genes and druggable targets2 years ago
- Estimating the direct effects of the genetic liabilities to bipolar disorder, schizophrenia, and behavioral traits on suicide attempt using a multivariable Mendelian randomization approach2 years ago
Journal of Psychopharmacology
- Effect of medication on risk of traumatic brain injury in patients with bipolar disorder: A nationwide population-based cohort study5 years ago
- Equasy revisited5 years ago
- The biologically active compound of Withania somnifera (L.) Dunal, docosanyl ferulate, is endowed with potent anxiolytic properties but devoid of typical benzodiazepine-like side effects5 years ago
- Selective attention to emotional stimuli and emotion recognition in patients with major depression: The role of mineralocorticoid and glutamatergic NMDA receptors5 years ago
- Discontinuation and relapse with paliperidone palmitate three-monthly for maintenance of schizophrenia: Two year follow-up of use in clinical practice5 years ago
- Easier patient access to medical cannabis carries risks as well as benefits5 years ago
- Hydrocortisone as an adjunct to brief cognitive-behavioural therapy for specific fear: Endocrine and cognitive biomarkers as predictors of symptom improvement5 years ago
European Neuropsychopharmacology
- The unrealized promise of cerebrovascular magnetic resonance imaging in psychiatric research across the lifespan5 years ago
- Recommendations for pharmacotranscriptomic profiling of drug response in CNS disorders5 years ago
- Corrigendum to “Abstracts of the Virtual World Congress of Psychiatric Genetics (WCPG), October 11-15, 2021 – Oral abstracts. [European Neuropsychopharmacology 51 (2021) e40–e93]”5 years ago
- The impact of the prolonged COVID-19 pandemic on stress resilience and mental health: a critical review across waves5 years ago
- Promoting good mental health in the whole population: The new frontier5 years ago
- Reduced prefrontal cortex response to own vs. unknown emotional infant faces in mothers with bipolar disorder5 years ago
- How to reduce and stop psychiatric medication5 years ago